Menu

World’s Last Male Northern White Rhino Dies

Only two members of the subspecies are now left alive.

Mar 20, 2018
Shawna Williams

Sudan with a handler in 2015FLICKR, MAKE IT KENYA/STUART PRICESudan, the last remaining northern white rhino to have been born in the wild, was euthanized yesterday (March 19) after his health deteriorated, Kenya’s Ol Pejeta Conservancy announced today. Only two members of the subspecies remain, Sudan’s daughter and granddaughter.

Most northern white rhinos were wiped out by poaching in the 1970s and ’80s, according to the conservancy’s statement, and by 2008 the subspecies was considered extinct in the wild. The Associated Press notes that Sudan took his name from the country where he was born; he was captured as a calf and kept in a Czech zoo until 2009, when he and other remaining members of the species were transferred to the Kenyan conservancy. He was 45 when he died, and caretakers made the decision to euthanize him because he was in pain and unable to stand.

His death “is a cruel symbol of human disregard for nature and it saddened everyone who knew him. But we should not give up,” Jan Stejskal, director of international projects at Dvur Kralove Zoo in the Czech Republic, tells the AP. “It may sound unbelievable, but thanks to the newly developed techniques even Sudan could still have an offspring.”

Scientists have harvested Sudan’s sperm, and that of other male white rhinos, prior to their deaths, NPR explains. Neither of the living females is capable of reproducing, but researchers hope to use their eggs to create embryos that could be implanted into southern white rhino females, which would act as surrogate mothers.

See “IVF to Revive Endangered White Rhino Population

Correction (March 21): The original version of this article erroneously stated that the northern white rhino is a species; it has been corrected to reflect the fact that it is a subspecies. The Scientist regrets the error.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.